Despite Draft Framework, Health IT Legislation Still Needed, Senators Say
This article was originally published in The Gray Sheet
FDA joined two other agencies last week in issuing a proposed new health information technology regulatory framework that would include risk-based oversight and only patient role for FDA. While Senators sponsoring health IT legislation to restrict FDA’s role praised some aspects of the report, they insisted their bill was still necessary. Meanwhile, Device trade groups, in balance, were positive about the propose framework.
You may also be interested in...
The PROTECT Act, which attempts to respond to some criticisms of the House SOFTWARE Act, aims to restrict FDA’s oversight of health information technology. It is backed by IBM and Verizon, among others.
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.